Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Benzinga Insights

12 Health Care Stocks Moving In Monday's After-Market Session

Gainers

  • GBS (NASDAQ:GBS) stock rose 10.9% to $0.51 during Monday's after-market session. The market value of their outstanding shares is at $7.5 million.
  • Checkpoint Therapeutics (NASDAQ:CKPT) shares rose 7.26% to $1.92. The company's market cap stands at $160.8 million.
  • Marker Therapeutics (NASDAQ:MRKR) shares moved upwards by 6.35% to $0.4. The market value of their outstanding shares is at $33.2 million.
  • Kala Pharmaceuticals (NASDAQ:KALA) stock increased by 5.74% to $0.7. The company's market cap stands at $50.6 million.
  • BIMI International (NASDAQ:BIMI) shares increased by 5.64% to $1.31. The company's market cap stands at $11.1 million.
  • OraSure Technologies (NASDAQ:OSUR) shares rose 5.38% to $8.22. The market value of their outstanding shares is at $592.4 million. The company's, Q4 earnings came out 3 days ago.

Losers

  • GoodRx Holdings (NASDAQ:GDRX) stock fell 27.8% to $19.78 during Monday's after-market session. Trading volume for this security closed at 260.1K, accounting for 16.1% of its average full-day volume over the last 100 days. The company's market cap stands at $7.8 billion. The company's, Q4 earnings came out today.
  • Avenue Therapeutics (NASDAQ:ATXI) stock declined by 13.51% to $0.29. This security traded at a volume of 67.0K shares come close, making up 10.2% of its average volume over the last 100 days. The company's market cap stands at $6.1 million.
  • Semler Scientific (NASDAQ:SMLR) stock declined by 10.96% to $65.0. The market value of their outstanding shares is at $439.2 million. The company's, Q4 earnings came out today.
  • Heron Therapeutics (NASDAQ:HRTX) stock declined by 9.86% to $6.4. The market value of their outstanding shares is at $652.3 million. As per the press release, Q4 earnings came out today.
  • Intellia Therapeutics (NASDAQ:NTLA) stock decreased by 8.96% to $90.0. The market value of their outstanding shares is at $6.7 billion. As per the press release, Q4 earnings came out 2 days ago.
  • FibroGen (NASDAQ:FGEN) shares declined by 8.32% to $12.9. Today's trading volume for this security ended up closing at 180.2K shares, which is 16.4 percent of its average volume over the last 100 days. The company's market cap stands at $1.1 billion. As per the news, the Q4 earnings report came out today. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.